Guangxi Medical University
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- 2000 liver cancer patients studied to uncover best Pre-Surgery treatments Results expected Dec 2026 (estimated)
- Office-Based blood pressure program aims to tame hypertension in young workers Results expected Jan 2027 (estimated)
-
New combo treatment shows promise for inoperable liver cancer
Disease control CompletedThis study tested a new treatment for people with liver cancer that cannot be removed by surgery. The treatment combines chemotherapy delivered directly to the liver, a procedure to block the tumor's blood supply, and two drugs (lenvatinib and tislelizumab). The goal was to see i…
Phase 2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New chemo combo shows promise for common throat cancer in southern china
Disease control CompletedThis study tested a new combination of chemotherapy drugs (nab-paclitaxel, cisplatin, and fluorouracil) given before standard chemoradiation in 60 people with advanced nasopharyngeal cancer. The goal was to see if this approach could shrink tumors and improve survival. The trial …
Phase 2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC